SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007382
Filing Date
2019-05-15
Accepted
2019-05-15 16:06:10
Documents
47
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 559063
2 ex31-1.htm EX-31.1 11837
3 ex31-2.htm EX-31.2 11702
4 ex32-1.htm EX-32.1 9277
  Complete submission text file 0001493152-19-007382.txt   2428598

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20190331.xml EX-101.INS 298516
6 XBRL SCHEMA FILE rttr-20190331.xsd EX-101.SCH 27060
7 XBRL CALCULATION FILE rttr-20190331_cal.xml EX-101.CAL 40280
8 XBRL DEFINITION FILE rttr-20190331_def.xml EX-101.DEF 108555
9 XBRL LABEL FILE rttr-20190331_lab.xml EX-101.LAB 228803
10 XBRL PRESENTATION FILE rttr-20190331_pre.xml EX-101.PRE 179140
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 19828012
SIC: 2834 Pharmaceutical Preparations